You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

68Ga-PSMA PET/CT

Showing 1 - 25 of 9,779
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Montreal (68Ga-HBED-CC-PSMA PET/CT)

Enrolling by invitation
  • Prostate Cancer
  • 68Ga-HBED-CC-PSMA PET/CT
  • Montreal, Quebec, Canada
    Jewish General Hospital
Oct 24, 2022

Hepatocellular Carcinoma Trial in Rochester (Gallium Ga 68 Gozetotide, Hepatic Artery Embolization, Positron Emission Tomography

Recruiting
  • Hepatocellular Carcinoma
  • Gallium Ga 68 Gozetotide
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 11, 2023

Hepatocellular Carcinoma Trial in Rochester (Ga-68 labeled PSMA-11, Possible liver biopsy for locoregional therapy group)

Recruiting
  • Hepatocellular Carcinoma
  • Ga-68 labeled PSMA-11
  • Possible liver biopsy for locoregional therapy group
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jul 18, 2022

Prostate Cancer Trial in Nanjing (68Ga-PSMA-33)

Recruiting
  • Prostate Cancer
  • Nanjing, Jiangsu, China
    68Ga-PSMA-33 PET/CT imaging
Sep 19, 2023

Prostate Cancer, PET/CT Trial in Hefei ([68Ga]Ga-PSMA-D5, [68Ga]Ga-PSMA-11)

Recruiting
  • Prostate Cancer
  • PET/CT
  • Hefei, Anhui, China
    The First Affiliated Hospital of China University of Science and
Jul 19, 2023

Prostate Cancer Trial in Beijing (Al18F-PSMA-617, 68Ga-PSMA-617)

Recruiting
  • Prostate Cancer
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 2, 2023

Salivary Gland Cancer, Salivary Duct Carcinoma Trial in Nijmegen (68Ga-PSMA-PET/CT, 18FDG-PET/CT)

Recruiting
  • Salivary Gland Cancer
  • Salivary Duct Carcinoma
  • 68Ga-PSMA-PET/CT
  • 18FDG-PET/CT
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Aug 15, 2022

Tumors Trial in Beijing ([68Ga]P3)

Recruiting
  • Neoplasms
  • Beijing, Beijing, China
    Peking University First Hospital
Jul 4, 2023

Glioma, Malignant, Glioma Glioblastoma Multiforme Trial in Warsaw ([68Ga]Ga-PSMA-11 PET/CT)

Completed
  • Glioma, Malignant
  • Glioma Glioblastoma Multiforme
  • [68Ga]Ga-PSMA-11 PET/CT
  • Warsaw, Mazowieckie, Poland
    Nuclear Medicne Department Medical University of Warsaw
May 29, 2023

Tumors Trial in Beijing ([68Ga]P3)

Recruiting
  • Neoplasms
  • Beijing, Beijing, China
    Peking University First Hospital
Jun 4, 2023

68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy

Enrolling by invitation
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Computed Tomography
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 16, 2023

68Ga-PSMA PET/CT Imaging in Assessment of Prostate Cancer

Completed
  • PET/CT
  • +2 more
  • total-body PET/CT
  • Shanghai, Shanghai, China
    Shanghai jiaotong University School of Medicine, Renji Hospital
Nov 15, 2021

Renal Cell Carcinoma Trial in Beijing (68Ga-PSMA, 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617)

Recruiting
  • Renal Cell Carcinoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Dec 24, 2021

Biochemically Recurrent Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Los

Terminated
  • Biochemically Recurrent Prostate Carcinoma
  • +5 more
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    University of California at Los Angeles / Jonsson Comprehensive
Oct 19, 2022

Prostate Cancer, High Risk Trial in Houston (68Ga-PSMA)

Active, not recruiting
Has Results
  • Prostate Cancer
  • High Risk
  • Houston, Texas
    Houston Methodist
Dec 8, 2022

Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Los Angeles (Computed Tomography, Gallium Ga 68 FAPi-46,

Recruiting
  • Breast Carcinoma
  • +10 more
  • Computed Tomography
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Nov 29, 2022

Prostate Cancer Trial in Beijing (68Ga-P16-093, 68Ga-PSMA-11)

Recruiting
  • Prostate Cancer
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Nov 1, 2022

Prostate Cancer, Prostate Tumor Trial in Chandigarh (PSMA PET guided prostate biopsy, MRI directed TRUS guided prostate biopsy)

Recruiting
  • Prostate Cancer
  • Prostate Neoplasm
  • PSMA PET guided prostate biopsy
  • MRI directed TRUS guided prostate biopsy
  • Chandigarh, ChandÄ«garh, India
    PGIMER
Nov 27, 2021

Prostate Cancer Metastatic Trial in Peking (68Ga-PSMA-11, 68Ga-P15-041)

Recruiting
  • Prostate Cancer Metastatic
  • Peking, China
    Peking Union Medical College Hospital
Nov 25, 2022

Biochemical Recurrence of Malignant Tumor of Prostate, Prostate Cancer, BCR Prostate Carcinoma Trial in China (68Ga-PSMA-11,

Not yet recruiting
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • +2 more
  • Changsha, China
  • +5 more
Apr 26, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on

Terminated
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 19, 2022

Prostate Adenocarcinoma, PSA Failure, Recurrent Prostate Carcinoma Trial in Palo Alto (Computed Tomography (CT) scan,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +2 more
  • Computed Tomography (CT) scan
  • +2 more
  • Palo Alto, California
    Stanford University, School of Medicine
Jan 6, 2022

Bladder Cancer Trial in New York ([68Ga]PSMA, PET/CT imaging)

Recruiting
  • Bladder Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 28, 2022

Prostate Cancer Trial in Beijing (68Ga-PSMA-617, 68Ga-P16-093)

Recruiting
  • Prostate Cancer
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 4, 2022

Prostate Cancer Trial (Radiopharmaceutical 68Ga-PSMA-11 PET/CT)

Not yet recruiting
  • Prostate Cancer
  • Radiopharmaceutical 68Ga-PSMA-11 PET/CT
  • (no location specified)
Oct 12, 2022